Carl C. Icahn has withdrawn his lawsuit against Amylin Pharmaceuticals, citing a conversation he had with the drug maker's chief executive. What exactly was said, however, remains a mystery.
m_delamercedMichael de la MercedIcahn called off Amylin fight after chat w/CEO, but didn't say was said. My take on "Lost in Translation"-like matter http://t.co/KuiI6tn6